This review summarizes the mechanisms of action and clinical activity of IMiDs in MM. Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic ...

Firefighters, police officer who responded to 9/11 in World Trade Center do have an increased risk of multiple myeloma. There are some other well-defined occupational exposures. For instance ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

21, 2024 — Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global population and causes painful, recurring skin lesions and inflammation, primarily in the folds ...

Multiple myeloma is part of the spectrum of diseases ranging from MGUS to plasma cell leukemia, and similar to MGUS, is characterized by proliferation of a plasma cell clone and subsequent ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

We conducted extensive experiments on two publicly available skin lesion segmentation datasets (ISIC2017 and ISIC2018). Our method achieved state-of-the-art results compared to previous studies. DSNET ...

Paying attention to early warning signs can help prevent AC from progression to skin cancer. The 10-year rate of malignant transformation of AK estimates range from 1% to 10% (the likelihood that the ...

Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized ... highlighting significant neuroimaging changes and clinical improvements. Patient A demonstrated substantial lesion ...